# Theophylline

NDC: 27241-272
Generic name: Theophylline
Labeler / Manufacturer: Ajanta Pharma USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20250326

FDA application: ANDA218401

## Active ingredients

- THEOPHYLLINE ANHYDROUS: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27241-272"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27241-272
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a422c32-bbdf-4297-84f4-9c438c904b0c